CTLA4 and malignant colon neoplasm: Therefore, a radiometal-chelated antibody against CD3 ([89Zr]Zr-DFO-CD3) was designed to quantify T-cell infiltration during anti-CTLA-4 treatment in colon cancer xenograft models.